Home Biotechnology AlzeCure Pharma
A

AlzeCure Pharma

Profile managed by Bizz Id

AlzeCure

Suecia 11-50 employees
Biotechnology CRO
Claim this profile

Description

Swedish biotech listed on Nasdaq First North, founded by ex-AstraZeneca scientists. Develops innovative treatments for Alzheimer's and CNS disorders (NeuroRestore®, Alzstatin® and Painless platforms). Recipient of a €2.5M EIC grant in 2025.

Contact company

Register for free to see this company’s contact details and get in touch.

Register - Free

We only use technical cookies that are necessary for the site to work and to keep you signed in. We do not use analytics or advertising cookies. Cookies